OneSource margin rebounds, but tax-free profit quality remains a watchpoint
Revenue growth outpaced costs and lifted operating margin sequentially, while higher interest and a zero tax rate shaped the quarter's profit outcome.
Filed 24 Jul 2026, 19:03 IST · after market close · OneSource Specialty Pharma Ltd (ONESOURCE)
Key takeaways
- Revenue grew 39.08% year on year while expenses rose 37.82%, lifting operating margin by 0.68 percentage points to 25.56%.
- Net profit more than doubled year on year to Rs 51.23 cr, but the comparison benefited from a zero tax rate and other income equal to 7.4% of pre-tax profit.
- Operating margin recovered 7.73 percentage points sequentially as revenue rose 6.57% and expenses fell 3.46%, though it remained below the Healthcare peer median of 28.65%.
Price around the results
Revenue momentum lifted operating profit
This standalone quarter showed revenue growth of 39.08% year on year and 6.57% sequentially. Operating profit rose 42.88% year on year and 52.76% sequentially, as expenses grew more slowly than revenue year on year and declined sequentially. The operating margin recovery from 17.83% in Q4FY26 to 25.56% was meaningful, but the margin remained 3.09 percentage points below the 28.65% median of 10 Healthcare peers that have reported.
Interest cost offset part of the operating recovery
The sequential margin improvement came with expenses falling 3.46% despite revenue rising 6.57%. Interest expense, however, increased 37.17% sequentially to Rs 30.52 cr and was up 12.91% year on year, limiting the conversion of operating profit into pre-tax profit. Other income contributed 7.4% of pre-tax profit, while the zero tax rate meant net profit equalled pre-tax profit and makes the reported earnings growth less representative of operating performance alone.
Margin recovery is uneven across the recent quarters
Operating margin has moved from 49.63% in Q4FY25 to 24.88% in Q1FY26, 27.07% in Q2FY26, 4.42% in Q3FY26, 17.83% in Q4FY26 and 25.56% now. The latest quarter therefore extends the recovery from the Q3FY26 trough, but does not restore the level seen in Q4FY25. Year on year, the margin expansion was limited to 0.68 percentage points.
The stock's response was positive but not unusual
The stock rose 2.12% on the initial reaction and was up 4.36% on the following day. That move was close to its recent typical absolute reaction of 1.92%, although the historical pattern has been negative more often, with two rises and five declines across seven results reactions. The history also includes a 19.62% fall, making the latest response notably less severe than its largest recent move.
Q1FY27 at a glance
Standalone figures as filed with NSE — cross-checked against an independent source.
| Line item | Q1FY27 | Q4FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹446 cr | ₹419 cr | +6.57% | +39.08% |
| Other income | ₹4 cr | ₹4 cr | +0.80% | -27.81% |
| Expenses | ₹332 cr | ₹344 cr | -3.46% | +37.82% |
| Operating profit | ₹114 cr | ₹75 cr | +52.76% | +42.88% |
| Operating margin (%) | 25.56% | 17.83% | — | — |
| Interest | ₹31 cr | ₹22 cr | +37.17% | +12.91% |
| Depreciation | ₹36 cr | ₹35 cr | +4.15% | +8.71% |
| Profit before tax | ₹51 cr | ₹21 cr | +138.50% | +106.41% |
| Tax | ₹0 cr | ₹0 cr | — | — |
| Net profit | ₹51 cr | ₹21 cr | +138.50% | +106.41% |
| EPS (₹) | ₹4.47 | ₹1.87 | +139.04% | +105.99% |
Operating margin of 25.56% compares with a Healthcare sector median of 28.65% across 10 peers that have reported Q1FY27.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | +2.12% | +1.15% |
| Next session | +4.36% | — |
Volume on the results session was 2.33× its 20-day average.
What to watch
- Whether operating margin holds above 25.56% after the sequential recovery of 7.73 percentage points.
- Whether interest expense moves below or above Rs 30.52 cr after its 37.17% sequential increase.
- Whether the tax rate remains at 0.0% and other income stays near 7.4% of pre-tax profit.